Spencer and Company LimitedUnlisted Shares
₹ 1,079▲0.00%(0.00)
About the company
Spencer and Company Limited is an Indian company with a long-standing presence in the business landscape. For investors interested in the private market, the company's unlisted shares offer an opportunity to gain exposure before any potential public listing or other significant corporate developments. Since these shares are not traded on stock exchanges, they are bought and sold through private transactions among eligible investors.
Investing in Spencer and Company Limited unlisted shares can be appealing for those looking to diversify their portfolio with privately held companies that may have long-term growth potential. However, as with any unlisted investment, it is important to carefully evaluate the company's financial performance, business model, management quality, industry outlook, and future growth prospects before making an investment decision.
Fundamentals
Valuation
- 52 week high
- ₹1,079
- 52 week low
- ₹1,079
- P/B ratio
- 0
- Debt to equity
- N/A
- ROE (%)
- N/A
- Book value
- N/A
- Face value
- —
- Valuation
- —
Registry
- ISIN number
- —
Frequently asked questions
Common questions on Spencer and Company Limited Unlisted Shares—tap a row to read the answer.
Q.1What are Spencer and Company Limited unlisted shares?
Spencer and Company Limited unlisted shares are equity shares of the company that are not listed on any recognized stock exchange in India. These shares are traded privately between buyers and sellers through authorized intermediaries. Investors often consider unlisted shares to diversify their portfolios and gain exposure to companies before a potential public listing.
Q.2How can I buy Spencer and Company Limited unlisted shares?
You can purchase Spencer and Company Limited unlisted shares through trusted dealers or investment platforms that facilitate private share transactions. Once the price and quantity are finalized, the shares are transferred directly to your Demat account after completing the required documentation and payment process.
Q.3Can I sell Spencer and Company Limited unlisted shares anytime?
Yes, you can sell your Spencer and Company Limited unlisted shares whenever you find a willing buyer. Since these shares are traded in the private market rather than on a stock exchange, the selling process depends on buyer availability, market demand, and agreed pricing.
Q.4Are Spencer and Company Limited unlisted shares a good investment?
The investment potential of Spencer and Company Limited unlisted shares depends on factors such as the company's financial performance, business fundamentals, future growth prospects, and industry outlook. Investors should carefully evaluate these factors and assess their own risk tolerance before investing in any unlisted company.
Q.5Is it legal to invest in Spencer and Company Limited unlisted shares in India?
Yes. Buying and selling unlisted shares is legal in India, provided the transaction complies with applicable regulations and is completed through a valid transfer process. Investors should always ensure that transactions are carried out with proper documentation and transferred to a registered Demat account.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
